An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.
Legal claims defining the scope of protection, as filed with the USPTO.
1. A method of detecting failures in an implanted analyte-responsive sensor, the method comprising: implanting an analyte-responsive sensor into a patient, the analyte-responsive sensor comprising N working electrodes, where N is an integer and is two or greater, and a common counter electrode; obtaining a signal generated at one of the N working electrodes and a signal generated at the common counter electrode; and determining failure of the analyte-responsive sensor if the signal from the common counter electrode is not N times the signal from the one of the N working electrodes.
2. The method of claim 1 wherein the determining step includes the step of comparing the signal generated at the one of the N working electrodes with the signal generated at the common counter electrode.
3. The method of claim 2 wherein the comparing step is initiated by the patient.
4. The method of claim 1 wherein the analyte-responsive sensor includes a glucose sensor.
5. The method of claim 1 further including the step of alerting the patient if the failure of the analyte-responsive sensor is determined.
6. The method of claim 5 wherein the step of alerting the patient includes the step of outputting one or more of an audio alert, a visual alert or a vibratory alert.
7. The method of claim 1 further including the steps of: replacing the analyte-responsive sensor implanted in the patient with another analyte-responsive sensor when failure of the sensor is determined.
8. The method of claim 7 further including the step of calibrating the another analyte-responsive sensor.
9. The method of claim 7 further including the step of alerting the patient to calibrate the another analyte-responsive sensor when a predetermined time interval has passed after the implantation of the another analyte-responsive sensor and calibration has not been performed.
10. The method of claim 9 wherein the step of alerting the patient includes the step of outputting one or more of an audio alert, a visual alert, or a vibratory alert.
11. The method of claim 1 further including the steps of: generating a respective signal at each of the N working electrodes; and comparing the respective generated signals to determine whether the generated respective signals are substantially within a predetermined level of tolerance.
12. The method of claim 11 , further including the step of alerting the patient to replace the analyte-responsive sensor when the generated respective signals are not substantially within the predetermined level of tolerance.
13. The method of claim 11 , further including the step of alerting the patient to replace the analyte-responsive sensor when the generated respective signals are not substantially in agreement for a predetermined period of time.
14. The method of claim 11 wherein the comparing step is performed at a predetermined time interval.
15. The method of claim 11 wherein the comparing step is initiated by the patient.
16. The method of claim 1 wherein the analyte-responsive sensor includes a subcutaneous sensor.
17. The method of claim 16 wherein the subcutaneous sensor includes a glucose sensor.
18. The method of claim 1 further including the step of calibrating the analyte-responsive sensor.
19. The method of claim 18 wherein the calibrating step includes the steps of: generating a signal from each of the N working electrodes; determining if the generated signals from the respective N working electrodes differ by substantially less than a first threshold level; and determining if the generated signals from the respective N working electrodes are within a predetermined range; and determining if a rate of change of the each respective signal from the corresponding one of the N working electrodes is less than a second threshold level.
20. The method of claim 18 wherein the calibrating step further includes the steps of: assaying a calibration sample of the patient's body fluid to determine a calibration value; and relating the calibration value to the at least one of the signals from the N working electrodes when the determining steps are satisfied.
Cooperative Patent Classification codes for this invention. Click any code to explore related patents in that topic.
November 24, 2003
March 13, 2007
Browse 5M+ US patents with plain-English claim translations and AI-generated analysis.